Business, energy, technology, markets and global industry news from Business News Today

Vesta Bladder Risk Stratify Dx

PharmaDeviceNews Vesta Bladder Risk Stratify Dx
Representative image: AI-powered digital pathology analysis for bladder cancer risk testing, highlighting how Valar Labs’ Vesta Bladder Risk Stratify Dx could support more precise non-muscle invasive bladder cancer prognosis after receiving FDA Breakthrough Device Designation.
Medical Devices & Diagnostics

Valar Labs FDA breakthrough nod signals new test for AI-led bladder cancer risk prediction

Bladder cancer risk tools leave gray zones. Valar Labs’ FDA breakthrough nod tests whether AI pathology can narrow them.

Read More